Trademark: 86749257
Word
ISM RESEARCH GROUP
Status
Dead
Status Code
606
Status Date
Monday, October 22, 2018
Serial Number
86749257
Mark Type
4000
Filing Date
Monday, September 7, 2015
Published for Opposition
Tuesday, July 26, 2016
Abandoned Date
Monday, October 22, 2018

Trademark Owner History
Maxim Temnikov - Owner At Publication

Classifications
5 A pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals, namely, for treatment of AIDS, infectious diseases; a pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on humans, namely, for AIDS, infectious diseases, a pharmaceutical composition featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 %, wherein the selected isotopes include stable isotopes having at least one of K-39, Mg -24, Zn-64, Rb-85, Si-26 and combination thereof and all other isotopes, wherein the pharmaceutical carrier is in the form of a solution, a gel, a cream, a spray, an aerosol, a patch, nanoparticles, inorganic molecules, organic molecules, a plant, a fruit and a vegetable, the pharmaceutical composition for treating AIDS, infectious diseases
44 medical services featuring a pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals featuring a pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of stable isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 % and administering a first of the stable isotopes at least prior to and after surgical removal of a solid tumor to prevent possible metastases and occurrence of secondary effects and to prevent metastasizing followed by administering a second of the stable isotopes to transform a cancer cell phenotype into a normal cell, wherein the pharmaceutical carrier and an isotope selective ingredient having at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100 %, wherein the selected isotopes include stable isotopes having at least one of K-39, Mg -24, Zn-64, Rb-85, Si-26 and combination thereof and all other isotopes, wherein the pharmaceutical carrier is in the form of a solution, a gel, a cream, a spray, an aerosol, a patch, nanoparticles, inorganic molecules, organic molecules, a plant, a fruit and a vegetable; medical testing for diagnostics purposes for diagnosis of pathology in biological objects featuring comparative analysis of light and heavy isotopes concentrations of vital chemical elements, wherein concentrations of light and heavy isotopes are compared to the ones corresponding to a natural distribution of isotopes for a given chemical element
"RESEARCH GROUP"

Trademark Events
Oct 22, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 22, 2018
Abandonment - No Use Statement Filed
Mar 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 20, 2018
Extension 3 Granted
Mar 20, 2018
Extension 3 Filed
Mar 20, 2018
Teas Extension Received
Sep 22, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 20, 2017
Extension 2 Granted
Sep 20, 2017
Extension 2 Filed
Sep 20, 2017
Teas Extension Received
Jul 18, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2017
Extension 1 Granted
Mar 20, 2017
Extension 1 Filed
Jul 14, 2017
Case Assigned To Intent To Use Paralegal
Jun 20, 2017
Notice Of Revival - E-Mailed
Jun 19, 2017
Extension Received With Teas Petition
Jun 19, 2017
Petition To Revive-Granted
Jun 19, 2017
Teas Petition To Revive Received
Apr 24, 2017
Abandonment Notice Mailed - No Use Statement Filed
Apr 24, 2017
Abandonment - No Use Statement Filed
Sep 20, 2016
Noa E-Mailed - Sou Required From Applicant
Jul 26, 2016
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2016
Published For Opposition
Jul 6, 2016
Notification Of Notice Of Publication E-Mailed
Jun 16, 2016
Approved For Pub - Principal Register
Jun 11, 2016
Teas/Email Correspondence Entered
Jun 11, 2016
Correspondence Received In Law Office
Jun 11, 2016
Teas Response To Office Action Received
Jun 11, 2016
Teas Response To Office Action Received
Dec 30, 2015
Notification Of Non-Final Action E-Mailed
Dec 30, 2015
Non-Final Action E-Mailed
Dec 30, 2015
Non-Final Action Written
Dec 18, 2015
Assigned To Examiner
Sep 10, 2015
New Application Office Supplied Data Entered In Tram
Sep 10, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24